The total saponin content of Anron ginseng drink is 136 times that of ordinary four-year ginseng, and the content of Rh2 and Rg3, which can inhibit the activity of tumor cells, are 82 times and 235,854 times that of ordinary four-year ginseng respectively.
A large number of studies have found that ginsenosides can produce significant anti-tumor effects by inhibiting the growth and proliferation of cancer cells, inducing cancer cell apoptosis, inhibiting cancer cell invasion and metastasis, and resisting tumor neovascularization.
Currently, ginsenosides have been widely used in adjuvant cancer treatment.
Enron’s ginseng stem cell technology has been researched and tested by the Enron Nano Stem Cell Research Institute team for many years. Through continuous technical exchanges and verifications, Enron’s ginseng stem cell technology has obtained two national invention patents and recognition.